Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tom Fitch"'
Publikováno v:
School Science and Mathematics. 96:120-127
Over the past decade, Illinois science education has experienced major reform efforts mandated by the state legislature. The end results of many of these mandates are not yet determined, although questions have arisen which bring some focus to the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31602f9fcfe5622deab57a68b4ff34d3
https://doi.org/10.1111/j.1949-8594.1996.tb15824.x
https://doi.org/10.1111/j.1949-8594.1996.tb15824.x
Autor:
Svetomir N. Markovic, William Sharfman, Tom Fitch, Susan Geyer, Charles Erlichman, Fitzroy Dawkins, Paula M. Fracasso, D O Patricia LoRusso, William Maples, Alex A. Adjei, Mark Albertini
Publikováno v:
Cancer. 103(12)
BACKGROUND Bortezomib is a proteasome inhibitor with manageable clinical toxicity and laboratory evidence of anti-melanoma activity. Therefore, it was considered for clinical testing in patients with metastatic melanoma. METHODS Patients with metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::502e992935a0f7425834ce027476dd25
https://pubmed.ncbi.nlm.nih.gov/15887220
https://pubmed.ncbi.nlm.nih.gov/15887220
Autor:
Scott H. Okuno, Michelle R. Mahoney, Charles Erlichman, Tom Fitch, James A. Stewart, Paula M. Fracasso, Fitzroy Dawkins, William J. Maples, Michael Kraut, David S. Ettinger
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(13)
Purpose Epothilones are a new class of nontaxane tubulin polymerization agents that have activity in taxane-resistant tumors. Epothilone B (BMS-247550) is a semisynthetic analog of the natural product epothilone B. This study was performed to determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50e524f7e8d58d29dfded8f12089a40
https://pubmed.ncbi.nlm.nih.gov/15860865
https://pubmed.ncbi.nlm.nih.gov/15860865